ArticleJournal of surgical oncology2026
Parotidectomy: 10-Year Experience in the Hands of Surgical Oncologists.
Article in Journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesParotidectomy is the most common salivary gland surgery, but there remains a paucity of literature regarding its outcomes in the hands of surgical oncologists.
methodsA retrospective review was conducted of all patients (n = 74) who underwent parotidectomy by surgical oncologists at a single institution over 10 years (2015-2025). Demographics, perioperative characteristics, and complications were compared. Associations between clinical factors and complications were evaluated by multivariate logistic regression.
resultsMost patients were White (85.1%) and male (51.4%) with a mean age of 59.9 years. The most common comorbidities were hypertension (48.6%), current smoking (40.5%), and anxiety (17.6%). Temporary facial nerve paresis occurred in 40.3% of patients by postoperative day one, with no cases of permanent facial nerve paresis. Frey's syndrome occurred in 9.0% and First Bite Syndrome (FBS) in 10.4% of tumor cases; a higher proportion of malignant cases experienced these complications in comparison to benign indications. Positive lymph node status was associated with FBS (p = 0.015), potentially reflecting more extensive surgical dissection. No significant risk factors were identified for other complications.
conclusionsThis study suggests that surgical oncologists with appropriate training can perform parotidectomies with complication rates within published ranges. Larger multicenter studies are needed to validate these findings and examine associations between clinical factors and rare complications, further establishing the role of surgical oncologists in parotidectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.